DK2323686T3 - Adiponectin til behandling af lungesygdom - Google Patents

Adiponectin til behandling af lungesygdom

Info

Publication number
DK2323686T3
DK2323686T3 DK09788056.1T DK09788056T DK2323686T3 DK 2323686 T3 DK2323686 T3 DK 2323686T3 DK 09788056 T DK09788056 T DK 09788056T DK 2323686 T3 DK2323686 T3 DK 2323686T3
Authority
DK
Denmark
Prior art keywords
adiponectin
treatment
lung disease
lung
disease
Prior art date
Application number
DK09788056.1T
Other languages
English (en)
Inventor
Keiko Karasutani
Kounori Kotosai
Kazuyoshi Kirima
Yasukazu Ohmoto
Yoichi Yabuuchi
Original Assignee
Otsuka Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Otsuka Pharma Co Ltd filed Critical Otsuka Pharma Co Ltd
Application granted granted Critical
Publication of DK2323686T3 publication Critical patent/DK2323686T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/2264—Obesity-gene products, e.g. leptin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/785—Alveolar surfactant peptides; Pulmonary surfactant peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Endocrinology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Genetics & Genomics (AREA)
  • Obesity (AREA)
  • Organic Chemistry (AREA)
  • Pulmonology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK09788056.1T 2008-08-27 2009-08-27 Adiponectin til behandling af lungesygdom DK2323686T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2008217721 2008-08-27
PCT/JP2009/065380 WO2010024460A1 (en) 2008-08-27 2009-08-27 Adiponectin for treating pulmonary disease

Publications (1)

Publication Number Publication Date
DK2323686T3 true DK2323686T3 (da) 2013-06-03

Family

ID=41478949

Family Applications (1)

Application Number Title Priority Date Filing Date
DK09788056.1T DK2323686T3 (da) 2008-08-27 2009-08-27 Adiponectin til behandling af lungesygdom

Country Status (25)

Country Link
US (2) US20110218146A1 (da)
EP (2) EP2323686B8 (da)
JP (2) JP5618993B2 (da)
KR (1) KR20110056394A (da)
CN (1) CN102292100A (da)
AR (1) AR073133A1 (da)
AU (1) AU2009284876A1 (da)
BR (1) BRPI0917149A2 (da)
CA (1) CA2735263A1 (da)
CO (1) CO6321161A2 (da)
CY (1) CY1114125T1 (da)
DK (1) DK2323686T3 (da)
ES (1) ES2421151T3 (da)
HR (1) HRP20130695T1 (da)
IL (2) IL211346A0 (da)
MX (1) MX2011002158A (da)
MY (1) MY152044A (da)
PL (1) PL2323686T3 (da)
PT (1) PT2323686E (da)
RU (2) RU2490023C2 (da)
SI (1) SI2323686T1 (da)
TW (2) TW201014598A (da)
UA (1) UA100296C2 (da)
WO (1) WO2010024460A1 (da)
ZA (1) ZA201101366B (da)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USRE45394E1 (en) 2008-10-20 2015-03-03 X6D Limited 3D glasses
US8542326B2 (en) 2008-11-17 2013-09-24 X6D Limited 3D shutter glasses for use with LCD displays
USD692941S1 (en) 2009-11-16 2013-11-05 X6D Limited 3D glasses
USD711959S1 (en) 2012-08-10 2014-08-26 X6D Limited Glasses for amblyopia treatment
JP2017525370A (ja) 2014-08-21 2017-09-07 ザ ジェネラル ホスピタル コーポレイション 腫瘍壊死因子スーパーファミリーおよびｔｎｆ様リガンドムテインならびに腫瘍壊死因子スーパーファミリーおよびｔｎｆ様リガンドムテインを調製および使用する方法
CN110724186A (zh) * 2019-10-29 2020-01-24 四川农业大学 西伯利亚鲟球形脂联素蛋白基因原核表达的方法及应用

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5869330A (en) * 1995-06-05 1999-02-09 Whitehead Institute For Biomedical Research DNA encoding a novel serum protein produced exclusively in adipocytes
CA2264928A1 (en) 1997-07-09 1999-01-21 Koji Kawai Antitussives
JP3538711B2 (ja) * 1997-10-29 2004-06-14 大塚製薬株式会社 平滑筋増殖抑制組成物、動脈硬化症診断方法及びそのキット
JP3018186B1 (ja) 1999-03-09 2000-03-13 大阪大学長 抗炎症剤、単球系細胞の増殖抑制剤
SI1324970T1 (sl) * 2000-10-02 2009-02-28 Hoffmann La Roche Retinoidi za zdravljenje emfizema
CA2473781A1 (en) * 2002-01-18 2003-07-31 Protemix Corporation Limited Glycoisoforms of adiponectin and uses thereof
US7419955B2 (en) * 2002-05-24 2008-09-02 Japan Science And Technology Agency Method for treating arteriosclerosis
JP4212304B2 (ja) 2002-06-14 2009-01-21 独立行政法人科学技術振興機構 Ａｍｐ活性化プロテインキナーゼ活性化剤
JP2004345968A (ja) * 2003-05-20 2004-12-09 Takashi Kadowaki アディポネクチンの新規用途
EP1830873A4 (en) * 2004-12-10 2008-04-02 Protemix Corp Ltd GLYPONECTIN (GLYCOSYLATED ADIPONEKTIN) FOR THE TREATMENT OF DISEASES AND CONDITIONS
CN101415461A (zh) * 2006-01-09 2009-04-22 儿童医院医疗中心 用于治疗各种疾病的脂连蛋白

Also Published As

Publication number Publication date
TW201500053A (zh) 2015-01-01
WO2010024460A1 (en) 2010-03-04
IL211346A0 (en) 2011-05-31
IL234693A0 (en) 2014-11-30
RU2490023C2 (ru) 2013-08-20
PT2323686E (pt) 2013-07-11
US20130345133A1 (en) 2013-12-26
HRP20130695T1 (hr) 2013-09-30
AU2009284876A1 (en) 2010-03-04
JP2015038090A (ja) 2015-02-26
JP5808470B2 (ja) 2015-11-10
CA2735263A1 (en) 2010-03-04
KR20110056394A (ko) 2011-05-27
ZA201101366B (en) 2012-05-30
EP2323686A1 (en) 2011-05-25
RU2011111432A (ru) 2012-10-10
HK1153644A1 (en) 2012-04-05
AR073133A1 (es) 2010-10-13
SI2323686T1 (sl) 2013-07-31
CN102292100A (zh) 2011-12-21
EP2323686B1 (en) 2013-05-15
EP2614831A1 (en) 2013-07-17
RU2013123003A (ru) 2014-11-27
JP5618993B2 (ja) 2014-11-05
JP2012501297A (ja) 2012-01-19
PL2323686T3 (pl) 2013-09-30
EP2323686B8 (en) 2013-07-03
CO6321161A2 (es) 2011-09-20
MY152044A (en) 2014-08-15
CY1114125T1 (el) 2016-07-27
TW201014598A (en) 2010-04-16
MX2011002158A (es) 2011-03-29
BRPI0917149A2 (pt) 2015-12-01
ES2421151T3 (es) 2013-08-29
UA100296C2 (uk) 2012-12-10
US20110218146A1 (en) 2011-09-08

Similar Documents

Publication Publication Date Title
DK2504005T3 (da) Anvendelse af 1,3-diphenylprop-2-en-1-on-derivater til behandling af lever-sygdomme
DK1874781T3 (da) Dihydrothienopyrimidiner til behandling af inflammatoriske sygdomme
DK3456707T3 (da) 4-(p-quinonyl)-2-hydroxybutanamidderivater til behandling af mitokondriesygdomme
DK3289876T3 (da) Forbindelser til behandling af cancer
DK2222272T3 (da) Behandling af luftvejssygdom
SMAP200900085A (it) 3-imidazolil-indoli per il trattamento di malattieproliferative
EP2114498A4 (en) INHALER
EP2142239A4 (en) INHALATION DEVICE
DK2300443T3 (da) Triazolderivater, der er anvendelige til behandling af sygdomme
BRPI0906366A2 (pt) Inalador
PL2338519T3 (pl) Środek do leczenia zwłóknienia szpiku
LTC2330892I2 (lt) Gydymo būdai panaudojant vaistus - amoniako gaudykles
DK2451482T3 (da) Kombinationsterapi til behandlingen af diabetes
BRPI0914817A2 (pt) inalador
DK2056842T3 (da) Modificeret galactosylceramid til behandling af cancerøse sygdomme
DK2285808T3 (da) Spiroindolderivater til behandling af parasitsygdomme
DK2209784T3 (da) Forbindelser til behandling af hepatitis C
BRPI0906779A2 (pt) Inalador
DK2173831T3 (da) Brøndbehandling
DK2117565T3 (da) Anvendelse af chitosaner til behandlingen af negleinflammatoriske sygdomme
DK2164572T3 (da) Carbamoyl-cyclohexaner til behandling af akut mani
BRPI0906367A2 (pt) inalador
DK2033675T3 (da) Inhalationsapparat
DK2056858T3 (da) Behandling af lungesygdomstilstande
BRPI0820410A2 (pt) Lactans substituídos terapêuticos